328 related articles for article (PubMed ID: 29196855)
1. Ultrasound-ultrasound image overlay fusion improves real-time control of radiofrequency ablation margin in the treatment of hepatocellular carcinoma.
Minami Y; Minami T; Hagiwara S; Ida H; Ueshima K; Nishida N; Murakami T; Kudo M
Eur Radiol; 2018 May; 28(5):1986-1993. PubMed ID: 29196855
[TBL] [Abstract][Full Text] [Related]
2. US-US Fusion Imaging in Radiofrequency Ablation for Liver Metastases.
Minami Y; Minami T; Chishina H; Kono M; Arizumi T; Takita M; Yada N; Hagiwara S; Ida H; Ueshima K; Nishida N; Kudo M
Dig Dis; 2016; 34(6):687-691. PubMed ID: 27750238
[TBL] [Abstract][Full Text] [Related]
3. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of the extracted-overlay function in CT/MR-ultrasonography fusion imaging for radiofrequency ablation of hepatocellular carcinoma.
Makino Y; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Hori M; Kudo M; Murakami T
Dig Dis; 2013; 31(5-6):485-9. PubMed ID: 24281025
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
Song KD; Lee MW; Rhim H; Kang TW; Cha DI; Sinn DH; Lim HK
Radiology; 2018 Sep; 288(3):878-886. PubMed ID: 29916771
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound fusion imaging technologies for guidance in ablation therapy for liver cancer.
Minami Y; Kudo M
J Med Ultrason (2001); 2020 Apr; 47(2):257-263. PubMed ID: 32125577
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation for hepatocellular carcinoma: Clinical value of ultrasound-ultrasound overlay fusion for optimal ablation and local controllability.
Minami Y; Minami T; Takita M; Hagiwara S; Ida H; Ueshima K; Nishida N; Kudo M
Hepatol Res; 2020 Jan; 50(1):67-74. PubMed ID: 31301213
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma.
Makino Y; Imai Y; Igura T; Hori M; Fukuda K; Sawai Y; Kogita S; Fujita N; Takehara T; Murakami T
Abdom Imaging; 2015 Jan; 40(1):102-11. PubMed ID: 25052767
[TBL] [Abstract][Full Text] [Related]
9. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma.
Ahn SJ; Lee JM; Lee DH; Lee SM; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
J Hepatol; 2017 Feb; 66(2):347-354. PubMed ID: 27650284
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the ablation margin of hepatocellular carcinoma using CEUS-CT/MR image fusion in a phantom model and in patients.
Li K; Su Z; Xu E; Huang Q; Zeng Q; Zheng R
BMC Cancer; 2017 Jan; 17(1):61. PubMed ID: 28103837
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of Extracted-Overlay Fusion Imaging for Intraoperative Treatment Evaluation of Radiofrequency Ablation for Hepatocellular Carcinoma.
Makino Y; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Iwamoto T; Okabe J; Takamura M; Fujita N; Hori M; Takehara T; Kudo M; Murakami T
Liver Cancer; 2016 Oct; 5(4):269-279. PubMed ID: 27781199
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance.
Xu ZF; Xie XY; Kuang M; Liu GJ; Chen LD; Zheng YL; Lu MD
J Clin Ultrasound; 2014; 42(6):321-30. PubMed ID: 24615771
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Local Tumor Progression after Radiofrequency Ablation (RFA) of Hepatocellular Carcinoma by Assessment of Ablative Margin Using Pre-RFA MRI and Post-RFA CT Registration.
Yoon JH; Lee JM; Klotz E; Woo H; Yu MH; Joo I; Lee ES; Han JK
Korean J Radiol; 2018; 19(6):1053-1065. PubMed ID: 30386137
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of hepatocellular carcinoma ablative margins using fused pre- and post-ablation hepatobiliary phase images.
Takeyama N; Mizobuchi N; Sakaki M; Shimozuma Y; Munechika J; Kajiwara A; Uchikoshi M; Uozumi S; Ohgiya Y; Gokan T
Abdom Radiol (NY); 2019 Mar; 44(3):923-935. PubMed ID: 30327828
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous ultrasonography-guided radiofrequency ablation of hepatocellular carcinomas: usefulness of image fusion with three-dimensional ultrasonography.
Park HJ; Lee MW; Rhim H; Cha DI; Kang TW; Lim S; Song KD; Lim HK
Clin Radiol; 2015 Apr; 70(4):387-94. PubMed ID: 25582889
[TBL] [Abstract][Full Text] [Related]
16. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.
Bo XW; Xu HX; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K; Wang D
Br J Radiol; 2017 Oct; 90(1078):20170063. PubMed ID: 28749166
[TBL] [Abstract][Full Text] [Related]
17. A feasibility study: evaluation of radiofrequency ablation therapy to hepatocellular carcinoma using image registration of preoperative and postoperative CT.
Fujioka C; Horiguchi J; Ishifuro M; Kakizawa H; Kiguchi M; Matsuura N; Hieda M; Tachikake T; Alam F; Furukawa T; Ito K
Acad Radiol; 2006 Aug; 13(8):986-94. PubMed ID: 16843851
[TBL] [Abstract][Full Text] [Related]
18. 3D fusion is superior to 2D point-to-point contrast-enhanced US to evaluate the ablative margin after RFA for hepatocellular carcinoma.
Long H; Zhou X; Zhang X; Ye J; Huang T; Cong L; Xie X; Huang G
Eur Radiol; 2024 Feb; 34(2):1247-1257. PubMed ID: 37572191
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography.
Lee MW; Rhim H; Cha DI; Kim YJ; Choi D; Kim YS; Lim HK
AJR Am J Roentgenol; 2012 Jun; 198(6):1438-44. PubMed ID: 22623560
[TBL] [Abstract][Full Text] [Related]
20. Assessment of radiofrequency ablation margin by MRI-MRI image fusion in hepatocellular carcinoma.
Wang XL; Li K; Su ZZ; Huang ZP; Wang P; Zheng RQ
World J Gastroenterol; 2015 May; 21(17):5345-51. PubMed ID: 25954109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
